Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Nu Holdings has shown it can acquire customers at scale, but the real test is monetization quality. This article brea...
Get a clear, real-world view of Ligand (LGND) 2026 earnings. This guide breaks down revenue sources, milestones, and ...
Coastal Florida homeowners on fixed incomes are confronting a dramatic rise in homeowners insurance. In one coastal c...
Micron Technology surged to a fresh all-time high after a blockbuster earnings report and strong AI-driven demand. Th...
A sharp move in Thomson Reuters stock has investors buzzing. AI-powered products and enterprise deals are at the hear...
Iranian strikes have sharply reduced Qatar's LNG output, cutting roughly 17% of capacity and threatening global suppl...
Biotech investors watched Agios Pharmaceuticals spark a notable rally after key quarterly results and a strong Aqvesm...
As Bank Montreal prepares to report its Q2 2026 results, investors want clarity on growth, credit quality, and return...
Ripple's private business shows strong growth while XRP trades near a $1 price. This article builds a practical, evid...
AeroVironment stock climbed today after a major government contract announcement. This article breaks down what happe...
A practical, scenario-driven look at predicting where SpaceX headed by 2026 and how investors can approach this high-...